Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Stroke therapy - study shows positive effects of Urokinase


Mechanical removal of blood clots is the therapy of choice for stroke patients. Peripheral, small blood vessels with reduced or blocked patency are, however, problematic. The study by the Department of Neurology and the University Institute for Diagnostic and Interventional Neuroradiology at Inselspital, Bern University Hospital, and the University of Bern demonstrates clear advantages of a simultaneous intra-arterial administration of Urokinase, a blood-clot-dissolving substance (thrombolytic).

Since 2015, the mechanical removal of the blood clot (endovascular mechanical thrombectomy) has been the standard procedure for treating patients with an occluded cerebral artery (stroke).

Mechanische Thrombektomie nach Stroke

J. Gralla, University Hospital Berne

Several randomized studies have shown that there is a relevant reduction in the degree of disability among stroke patients with this therapy.

Endovascular mechanical thrombectomy has been routinely performed at Inselspital since 2010. Between 300-400 patients are treated at Neurozentrum every year. Currently, the scientific focus in the area of endovascular stroke therapy lies primarily on expanding the area of use for the procedure, organizing stroke networks as well as improving the restoration of blood flow (reperfusion).

Objective: To improve the patency of blood vessels

In a meta-analysis published in 2018 (doi: 10.1136/jnnp-2017-317602), the research team led by Dr. Kaesmacher, Prof. Gralla and Prof. Fischer was able to show that there was a statistically significant and relevant difference for the patient as to whether the brain tissue is completely (so-called TICI3 result) or almost completely refused (so-called TICI2b result)1 with mechanical thrombectomy.

Therefore, intensive research is being conducted into ways of further improving reperfusion when no further mechanical improvements can be achieved. Apart from invasive rescue treatments such as inserting a permanent stent into a cerebrovascular vessel, a recently published study in Bern showed that the administration of coagulation-dissolving medicines (thrombolytics) through the catheter could improve the reperfusion result and thus reduce the degree of disability, without increasing the risk of bleeding.

Dr. Kaesmacher reports: “Until now, the significance of administering intra-arterial thrombolytic medicines following mechanical thrombectomy has not been clarified.

Accordingly, the recommendation of the American Stroke Association regarding its use has been cautious. The published results of the study thus constitute an important component in defining the future significance of the intra-arterial administration of fibrinolytics.”

Intra-arterial dissolution of blood clots has potential for improvement

The patients analyzed in the study (doi: 10/1001/jamaneurol.2019.4192) published in JAMA Neurology showed residual peripheral occlusions subsequent to mechanical thrombectomy, which led to an almost complete rather than a complete reperfusion.

The authors of the study were able to show that these peripheral occlusions could often be dissolved with the intra-arterial administration of a special thrombolytic (Urokinase) and thereby further improve reperfusion.

This was also reflected in a better outcome among the patients. In particular, it is important to note that the study found no increased risk of bleeding following the additional intra-arterial administration of Urokinase. The risk of symptomatic bleeding after the intra-arterial administration of Urokinase was 5.2% and 6.9% in the control group.

“Further studies are still needed for a widespread use of this procedure, and a pan-European, multicenter study is already well under way,” explains Prof. Dr. Jan Gralla, the neuroradiological senior author of the study. Co-supervisor of the study, Prof. Dr. Urs Fischer, summarizes: “The chosen approach constitutes a promising therapeutic strategy with which the therapeutic benefit of endovascular stroke treatment can be further improved. For patients with a low risk of bleeding, this means it is now more important than ever to do everything possible to further improve the reperfusion result.”

Wissenschaftliche Ansprechpartner:

- Prof. Dr. med. Jan Gralla
- Prof. Dr. med. Urs Fischer
- Dr. med. J. Kaesmacher


Kaesmacher J, Bellwald S, Dobrocky T. 2019: Safety and Efficacy of Intra-arterial Urokinase After Failed, Unsuccessful or incomplete Mechanical Thrombectomy in Anterior Circulation Large-Vessel Occlusion Stroke; doi: 10/1001/jamaneurol.2019.4192

Marcel Wyler | Universitätsspital Bern
Further information:

Further reports about: STROKE Urokinase blood flow blood vessels brain tissue stroke therapy thrombolytic

More articles from Medical Engineering:

nachricht The human body as an electrical conductor, a new method of wireless power transfer
07.04.2020 | Universitat Pompeu Fabra - Barcelona

nachricht Artificial intelligence can speed up the detection of stroke
31.03.2020 | University of Turku

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Belle II yields the first results: In search of the Z′ boson

The Belle II experiment has been collecting data from physical measurements for about one year. After several years of rebuilding work, both the SuperKEKB electron–positron accelerator and the Belle II detector have been improved compared with their predecessors in order to achieve a 40-fold higher data rate.

Scientists at 12 institutes in Germany are involved in constructing and operating the detector, developing evaluation algorithms, and analyzing the data.

Im Focus: When ions rattle their cage

Electrolytes play a key role in many areas: They are crucial for the storage of energy in our body as well as in batteries. In order to release energy, ions - charged atoms - must move in a liquid such as water. Until now the precise mechanism by which they move through the atoms and molecules of the electrolyte has, however, remained largely unknown. Scientists at the Max Planck Institute for Polymer Research have now shown that the electrical resistance of an electrolyte, which is determined by the motion of ions, can be traced back to microscopic vibrations of these dissolved ions.

In chemistry, common table salt is also known as sodium chloride. If this salt is dissolved in water, sodium and chloride atoms dissolve as positively or...

Im Focus: Harnessing the rain for hydrovoltaics

Drops of water falling on or sliding over surfaces may leave behind traces of electrical charge, causing the drops to charge themselves. Scientists at the Max Planck Institute for Polymer Research (MPI-P) in Mainz have now begun a detailed investigation into this phenomenon that accompanies us in every-day life. They developed a method to quantify the charge generation and additionally created a theoretical model to aid understanding. According to the scientists, the observed effect could be a source of generated power and an important building block for understanding frictional electricity.

Water drops sliding over non-conducting surfaces can be found everywhere in our lives: From the dripping of a coffee machine, to a rinse in the shower, to an...

Im Focus: A sensational discovery: Traces of rainforests in West Antarctica

90 million-year-old forest soil provides unexpected evidence for exceptionally warm climate near the South Pole in the Cretaceous

An international team of researchers led by geoscientists from the Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI) have now...

Im Focus: Blocking the Iron Transport Could Stop Tuberculosis

The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply. When the iron transport into the bacteria is inhibited, the pathogen can no longer grow. This opens novel ways to develop targeted tuberculosis drugs.

One of the most devastating pathogens that lives inside human cells is Mycobacterium tuberculosis, the bacillus that causes tuberculosis. According to the...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

13th AKL – International Laser Technology Congress: May 4–6, 2022 in Aachen – Laser Technology Live already this year!

02.04.2020 | Event News

Latest News

Innovative Technologies for Satellites

07.04.2020 | Information Technology

What cells does the novel coronavirus attack?

07.04.2020 | Life Sciences

Fraunhofer IWKS Starts Project “BReCycle” on Efficient Recycling of Fuel Cells

07.04.2020 | Power and Electrical Engineering

Science & Research
Overview of more VideoLinks >>>